82 results
Page 3 of 5
8-K
EX-1.1
gvbravw874r 3fyqm
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-1.1
viuaeaqzdq 5hgh
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
DEFA14A
as738x8w h7lx20ib6
10 Aug 20
Additional proxy soliciting materials
12:26pm
DEFA14A
4w14pjz2rryi4 sb
29 Apr 20
Additional proxy soliciting materials
4:17pm
PRE 14A
gc3htaeqmonyn
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-1.1
qkzyktutx l2lb
27 Mar 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-10.1
50l5w olw44l
26 Dec 19
Entry into a Material Definitive Agreement
4:15pm
D
u5fqowe
20 Dec 19
$8.56M in equity / debt / securities to be acquired, sold $8.56M, 151 investors
4:06pm
8-K
EX-10.1
qxemqp9q0pii1tdh32w6
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
D
jjzt23kq1v72su jl0js
31 Jul 19
$2.81M in debt / options / securities to be acquired, sold $2.81M, 86 investors
10:13am
8-K
EX-10.1
rvb5oaqa6 txzpq
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am